Evidence map›Paper›PMID 39685734›Full record

ArticleJournal of clinical medicine2024

Associations Between Polymorphisms of Genes Related to Vitamin D Pathway and the Response to Vedolizumab and Ustekinumab in Inflammatory Bowel Disease.

Jessica Cusato, Davide Giuseppe Ribaldone, Antonio D Avolio, Valentina Infusino, Miriam Antonucci, Gian Paolo Caviglia, Angelo Armandi, Linda Ceccarelli, Francesco Costa, Andrea Bottari and 3 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of clinical medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Jessica CusatoDepartment of Medical Sciences, University of Turin, 10126 Turin, Italy.ORCID 0000-0003-1977-9694
Davide Giuseppe RibaldoneDepartment of Medical Sciences, University of Turin, 10126 Turin, Italy.ORCID 0000-0002-9421-3087
Antonio D AvolioDepartment of Medical Sciences, University of Turin, 10126 Turin, Italy.ORCID 0000-0002-1321-4126
Valentina InfusinoDepartment of Medical Sciences, University of Turin, 10126 Turin, Italy.
Miriam AntonucciSCDU Infectious Diseases, Amedeo di Savoia Hospital, ASL Città di Torino, 10149 Turin, Italy.ORCID 0000-0002-5344-9659
Gian Paolo CavigliaDepartment of Medical Sciences, University of Turin, 10126 Turin, Italy.ORCID 0000-0002-0529-9481
Angelo ArmandiDepartment of Medical Sciences, University of Turin, 10126 Turin, Italy.ORCID 0000-0002-7245-4445
Linda CeccarelliAzienda Ospedaliera Universitaria Pisana, 56126 Pisa, Italy.
Francesco CostaAzienda Ospedaliera Universitaria Pisana, 56126 Pisa, Italy.ORCID 0000-0002-9150-3345
Andrea BottariAzienda Ospedaliera Universitaria Pisana, 56126 Pisa, Italy.ORCID 0000-0001-5343-7271
Pietro FeAzienda Ospedaliera Universitaria Pisana, 56126 Pisa, Italy.
Lorenzo BertaniAzienda Ospedaliera Universitaria Pisana, 56126 Pisa, Italy.ORCID 0000-0001-8653-1790
Francesca De VitaDepartment of Medical Sciences, University of Turin, 10126 Turin, Italy.

Funding

Research Grant of the University of Turin RIBD_RILO_22_01
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

advanced therapyalpha4beta7anti-IL12/23anti-integrinbiologicsCrohn’s diseasepredictiontailored therapytarget therapyulcerative colitis

Identifiers

PMID39685734
PMCPMC11642376

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.